Neurona Therapeutics

Neurona Therapeutics is a privately held, clinical-stage biotherapeutics company focused on developing regenerative neural cell therapies to treat chronic diseases of the nervous system. They are driven by a vision to create safe and effective cell therapies through rigorous science, collaborative innovation, and groundbreaking regenerative technology. Neurona's unique approach utilizes allogeneic, off-the-shelf cell therapies that permanently integrate into neural circuits, replace affected cells, and rebalance dysregulated electrical activity to repair the nervous system. Their lead product candidate, NRTX-1001, is a first-in-class inhibitory neuron therapy for epilepsy, currently being investigated in a Phase I/II clinical trial.

Neurona's research is based on nearly two decades of scientific discovery, originating from the University of California, San Francisco. They have built a robust regenerative medicine discovery platform and developed proprietary methods to manufacture specific types of fully-differentiated neuronal, glial, and gene-edited cell therapy candidates. Their team of innovators is working tirelessly to advance these cell therapies to address significant unmet medical needs in patients with neurological disorders, including epilepsy and Alzheimer's disease. Neurona is committed to creating a new generation of cell therapies that have the potential to revolutionize medical treatment for those living with chronic disorders of the nervous system.

Neurona Therapeutics is committed to offering flexible work arrangements, including paid parental leave and company-paid holidays. They also provide a competitive compensation package and various benefits to support the needs and well-being of their employees.

Neurona Therapeutics provides competitive compensation and benefits to its employees, including medical, dental, and vision insurance, as well as life insurance. They offer a pre-tax flexible spending account for health, dependent care, and a commuter benefit plan. Employees are also eligible for a 401(k) retirement savings plan and a Roth after-tax retirement savings plan, both of which include a company match. Additional benefits include an employee assistance program, disability, voluntary pet insurance, vacation, sick leave, paid parental leave, and company-paid holidays.

Neurona Therapeutics is a privately held, clinical-stage biotherapeutics company dedicated to developing safe and effective cell therapies for chronic neurological disorders. Their mission is to achieve this through rigorous scientific research, collaborative innovation, and groundbreaking regenerative technology. They believe that specific neural cell lineages have the unique ability to integrate and repair dysregulated neural circuits and are developing a pipeline of off-the-shelf, allogeneic cell therapies that could provide long-term treatment for patients with unmet medical needs.

Neurona Therapeutics fosters a collaborative and innovative culture where scientific excellence, integrity, and passion are highly valued. The company encourages teamwork, diverse perspectives, and a commitment to compassion, striving to create a supportive and engaging work environment for its employees. Their Culture Committee actively organizes events and programs like happy hours, a hiking club, a book club, health and wellness initiatives, and a career development program, all aimed at fostering a positive and enriching work experience.

Neurona Therapeutics is committed to diversity, equity, and inclusion in all aspects of its operations, particularly in its clinical trials. The company believes that diverse participation in clinical trials is essential to ensure that its therapies are safe and effective for all populations. Neurona actively seeks to diversify its workforce and collaborates with organizations like MESA to provide internship opportunities to students from underrepresented backgrounds. The company emphasizes a culture of respect and inclusion where all voices are heard and valued.